Malinda J Bender, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4802 Shannon Dr, Bellevue, NE 68133 Phone: 402-955-7605 Fax: 402-955-7601 |
Dr. Manju L. Patney, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Dr Ste 210, Bellevue, NE 68005 Phone: 402-292-5594 Fax: 402-292-5832 |
Kody A Moffatt, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11507 S 42nd St Ste 101, Bellevue, NE 68123 Phone: 402-955-7600 |
Dr. Valerie L Edwards, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Road, Bellevue, NE 68123 Phone: 402-294-6077 |
Monique L Macklem, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11507 South 42nd Street, Suite 101, Bellevue, NE 68123 Phone: 402-955-7600 |
Dr. Chitrita G Roy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 W Mission Ave, Suite A, Bellevue, NE 68005 Phone: 402-991-5437 Fax: 402-991-5497 |
Alison Allen, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Bellevue, NE 68123 Phone: 402-294-6077 |
Dr. Clancy Ellen Mcnally, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11507 S 42nd St, Bellevue, NE 68123 Phone: 402-955-7600 Fax: 402-955-7601 |
Steven S. Sindelar, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11507 S 42nd St Ste 101, Bellevue, NE 68123 Phone: 402-955-7600 |
News Archive
Nationwide Children's Hospital will break ground on property west of Parsons Avenue and north of Livingston Avenue in early 2010 for its third research facility as the last piece of its $840 million strategic facilities expansion plan, first announced in 2005. Nationwide Children's Board approval of the final construction budget is expected in early 2010.
A novel gut-to-brain neural circuit establishes the vagus nerve as an essential component of the brain system that regulates reward and motivation, according to research conducted at the Icahn School of Medicine at Mount Sinai and published September 20 in the journal Cell.
Chelsea Therapeutics International, Ltd. has successfully reached its target enrollment of 150 patients in its Northeraâ„¢ (Droxidopa) pivotal Phase III Study 301 for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH). Results from the trial are expected in September 2010 and the full registration program is on track to initiate a new drug application (NDA) in the first half of 2011.
Incomplete access to private databases containing vital genetic information may hinder the development of personalized medicine, say researchers.
Americans do not believe that they know much about depression, but are highly aware of the risks of not receiving care, according to a survey released by the National Alliance on Mental Illness (NAMI).
› Verified 3 days ago